| • |
 |
Active Aging |
|
| • |
|
Alzheimer’s Disease |
|
| • |
|
Anxiety and Neurotic Disorders |
|
| • |
|
Behavioral and Psychological Symptoms of Dementia |
|
| • |
|
Biological Diagnosis |
|
| • |
|
Caregiver Issues |
|
| • |
|
Cognitive-Behavioral Therapy |
|
| • |
|
Curriculum Development |
|
| • |
|
Delirium |
|
| • |
|
Dementia with Lewy Bodies |
|
| • |
|
Diagnostic Methods |
|
| • |
|
Environment and Design of Care Facilities |
|
| • |
|
Ethical and Legal Issues |
|
| • |
|
Ethno-cultural Psychogeriatrics |
|
| • |
|
Fronto-Temporal Dementia |
|
| • |
|
Genetics |
|
|
| • |
|
Hormone Replacement Therapy |
|
| • |
|
Interface of Psychogeriatrics with other Disciplines |
|
| • |
|
Late Life Depression |
|
| • |
|
Late Life Psychotic Disorders |
|
| • |
|
Management - including Dementia |
|
| • |
|
Mild Cognitive Impairment |
|
| • |
|
Molecular Biology |
|
| • |
|
Neglected Areas of Aging |
|
| • |
|
Neuroimaging |
|
| • |
|
Neuron Degeneration and Regeneration |
|
| • |
|
Neuroprotection |
|
| • |
|
Neuropsychiatric Diseases |
|
| • |
|
Nursing |
|
| • |
|
Nutrition and Aging |
|
| • |
|
Outcome Measures in Clinical Trials |
|
|
| • |
|
Palliative Care / End of Life |
|
| • |
|
Parkinson’s Disease Dementia |
|
| • |
|
Personality Disorders |
|
| • |
|
Pharmacoeconomics |
|
| • |
|
Polypharmacy and Drug
Interactions |
|
| • |
|
Psychogeriatric Training |
|
| • |
|
Psychosis |
|
| • |
|
Psychosocial Interventions |
|
| • |
|
Psychotherapy |
|
| • |
|
Service Delivery |
|
| • |
|
Sleep |
|
| • |
|
Suicide |
|
| • |
|
Training |
|
| • |
|
Trans-cultural Factors |
|
| • |
|
Treatments for Dementia |
|
| • |
|
Vascular Cognitive Impairment |
|
| • |
|
Vascular Dementia |
|
